نتایج جستجو برای: inactivating mutations

تعداد نتایج: 178132  

2011
Steven M. Sorscher Aubrey E. Hill Roger Belizaire Eric J. Sorscher

reported in Aging that murine embryo fibroblasts (MEFs) undergo p53 mutations and subsequent immortalizations in culture. This " release from cell cycle arrest " occurs in murine fibroblasts with a humanized or murine WT p53 [1]. The authors also noted that the cultured cells had frequently sustained a mutation matching a human tumor p53 mutation. Jang, et al. also reported spontaneous " immort...

2014
Manuel Montero Mehdi Rahimpour Alejandro M. Viale Goizeder Almagro Gustavo Eydallin Ángel Sevilla Manuel Cánovas Cristina Bernal Ana Belén Lozano Francisco José Muñoz Edurne Baroja-Fernández Abdellatif Bahaji Hirotada Mori Francisco M. Codoñer Javier Pozueta-Romero

In Escherichia coli, ppGpp is a major determinant of growth and glycogen accumulation. Levels of this signaling nucleotide are controlled by the balanced activities of the ppGpp RelA synthetase and the dual-function hydrolase/synthetase SpoT. Here we report the construction of spoT null (ΔspoT) mutants obtained by transducing a ΔspoT allele from ΔrelAΔspoT double mutants into relA+ cells. Iodin...

Journal: :Carcinogenesis 2004
Jong Woo Lee Young Hwa Soung Su Young Kim Suk Woo Nam Chang Jae Kim Yong Gu Cho Jong Heun Lee Hong Sug Kim Won Sang Park Sang Ho Kim Jung Young Lee Nam Jin Yoo Sug Hyung Lee

Evidence exists that deregulation of apoptosis is involved in the mechanisms of cancer development, and the somatic mutations of apoptosis-related genes have been reported in human cancers. Bcl-XL/Bcl-2-associated death promoter (Bad), a proapoptotic member of Bcl-2 family, plays an important role in the intrinsic apoptosis pathway. To explore the possibility that the genetic alterations of Bad...

2015
Adriana Mangue Esquiaveto-Aun Maricilda Palandi De Mello Maria Fernanda Vanti Macedo Paulino Walter José Minicucci Gil Guerra-Júnior Sofia Helena Valente De Lemos-Marini

BACKGROUND Permanent neonatal diabetes mellitus (PNDM) is a rare disorder, characterized by uncontrolled hyperglycemia diagnosed during the first 6 months of life. In general, PNDM has a genetic origin and most frequently it results from heterozygous mutations in KCNJ11, INS and ABCC8 genes. Homozygous or compound heterozygous inactivating mutations in GCK gene as cause of PNDM are rare. In con...

2016
Leman Damla Kotan Charlton Cooper Şükran Darcan Ian M. Carr Samim Özen Yi Yan Mohammad K. Hamedani Fatih Gürbüz Eda Mengen İhsan Turan Ayça Ulubay Gamze Akkuş Bilgin Yüksel A. Kemal Topaloğlu Etienne Leygue

OBJECTIVE What initiates the pubertal process in humans and other mammals is still unknown. We hypothesized that gene(s) taking roles in triggering human puberty may be identified by studying a cohort of idiopathic hypogonadotropic hypogonadism (IHH). METHODS A cohort of IHH cases was studied based on autozygosity mapping coupled with whole exome sequencing. RESULTS Our studies revealed thr...

Journal: :Biochemical Society transactions 2005
B Leighton A Atkinson M P Coghlan

The monomeric enzyme GK (glucokinase) has a low affinity for glucose and, quantitatively, is largely expressed in the liver and pancreatic beta-cells, playing a key 'glucose sensing' role to regulate hepatic glucose balance and insulin secretion. Mutations of GK in man can be inactivating, to cause a form of diabetes mellitus, or activating, to lower blood glucose levels. Recently, models of GK...

Journal: :Cancer research 2003
Paula M Hempen Lin Zhang Ravi K Bansal Christine A Iacobuzio-Donahue Kathleen M Murphy Anirban Maitra Bert Vogelstein Robert H Whitehead Sanford D Markowitz James K V Willson Charles J Yeo Ralph H Hruban Scott E Kern

The activin signaling pathway parallels the transforming growth factor (TGF)-beta pathway. Both use extracellular ligands and cell surface receptors that are structurally and functionally related, as well as the same intracellular mediators (SMADs 2-4) to transmit these signals. Members of both pathways have been characterized previously as tumor suppressor genes on the demonstration of inactiv...

2017
Lixiang Ma Hexige Saiyin

Pancreatic cancer (PC) accumulates multiple genetic mutations, including activating KRAS mutations and inactivating TP53, SMAD4 and CDKN2A mutations, during progression. The combination of mutant KRAS with a single inactivating TP53, SMAD4 or CDKN2A mutation in genetically engineered mouse models (GEMMs) showed that these mutations exert different synergistic effects in PC. However, the effect ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید